Company Filing History:
Years Active: 2018-2019
Title: Anjum Zafar: Innovator in Cancer Research
Introduction
Anjum Zafar is a notable inventor based in Bruce, Australia. He has made significant contributions to the field of cancer research, particularly in the modulation of cancer stem cells. With a total of 3 patents to his name, Zafar's work is paving the way for innovative treatments in oncology.
Latest Patents
Zafar's latest patents focus on compositions and methods for modulating cancer stem cells. One of his key inventions is titled "Compositions for modulating cancer stem cells and uses therefor." This patent discloses the use of lysine demethylase (LSD) inhibitors and protein kinase C theta inhibitors (PKC-θ) to inhibit the growth of LSD- and/or PKC-θ-overexpressing cells, including cancer stem cells. The invention aims to enhance the biological effects of chemotherapeutic drugs or irradiation on cancer cells, treat various forms of cancer, and prevent cancer recurrence. Another significant patent is "Methods and compositions for modulating cancer stem cells," which also utilizes lysine demethylase inhibitors for similar therapeutic purposes.
Career Highlights
Throughout his career, Anjum Zafar has worked with esteemed organizations such as the University of Canberra and Epiaxis Therapeutics Pty Ltd. His research has been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.
Collaborations
Zafar has collaborated with various professionals in his field, including Sudha Rao, who has contributed to his research endeavors.
Conclusion
Anjum Zafar's innovative work in cancer research highlights the potential for new treatments targeting cancer stem cells. His patents represent a significant step forward in the fight against cancer, showcasing the importance of continued research and collaboration in this critical area of medicine.